A role for prolyl hydroxylase domain proteins in hippocampal synaptic plasticity

Hippocampus

Volumn 23, Issue 10, 2013, Pages 861-872

  Corcoran, Alan ^a   Kunze, Reiner ^b   Harney, Sarah C ^c   Breier, Georg ^d   Marti, Hugo H ^b   O'Connor, John J ^a  

^a UNIVERSITY COLLEGE DUBLIN   (Ireland)

^b UNIVERSITY OF HEIDELBERG   (Germany)

^c TRINITY COLLEGE DUBLIN   (Ireland)

^d CENTER FOR REGENERATIVE THERAPIES DRESDEN   (Germany)

Author keywords

Dimethyloxalyl glycine; HIF 1alpha; Hippocampus; Hypoxia; Long term potentiation; Prolyl hydroxylase domain

Indexed keywords

JNJ 42041935; OXYGENASE INHIBITOR; PROCOLLAGEN PROLINE 2 OXOGLUTARATE 4 DIOXYGENASE; UNCLASSIFIED DRUG; DEFEROXAMINE; DICARBOXYLIC AMINO ACID; HIF1A PROTEIN, RAT; HYPOXIA INDUCIBLE FACTOR 1ALPHA; OXALYLGLYCINE;

ANIMAL CELL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DRUG EFFECT; ENZYME INHIBITION; EXCITATORY POSTSYNAPTIC POTENTIAL; HIPPOCAMPUS; LONG TERM POTENTIATION; MALE; NERVE CELL NECROSIS; NERVE CELL PLASTICITY; NONHUMAN; PRIORITY JOURNAL; PROTEIN FUNCTION; RAT; SYNAPTIC TRANSMISSION; ANIMAL; ANTAGONISTS AND INHIBITORS; CYTOLOGY; DEVICES; DRUG EFFECTS; ENZYMOLOGY; HIPPOCAMPAL CA1 REGION; KNOCKOUT MOUSE; MOUSE; PATCH CLAMP TECHNIQUE; PATHOLOGY; PHYSIOLOGY; WISTAR RAT;

AMINO ACIDS, DICARBOXYLIC; ANIMALS; CA1 REGION, HIPPOCAMPAL; DEFEROXAMINE; EXCITATORY POSTSYNAPTIC POTENTIALS; HIPPOCAMPUS; HYPOXIA-INDUCIBLE FACTOR 1, ALPHA SUBUNIT; LONG-TERM POTENTIATION; MALE; MICE; MICE, KNOCKOUT; PATCH-CLAMP TECHNIQUES; PROCOLLAGEN-PROLINE DIOXYGENASE; RATS; RATS, WISTAR;

EID: 84884715924     PISSN: 10509631     EISSN: 10981063     Source Type: Journal    
DOI: 10.1002/hipo.22142     Document Type: Article

References (43)

1. Ahn HJ, Hernandez CM, Levenson JM, Lubin FD, Liou HC, Sweatt JD. 2008. c-Rel, an NF-kappaB family transcription factor, is required for hippocampal long-term synaptic plasticity and memory formation. Learn Mem 15:539-549.
2. Aragonés J, Schneider M, Van Geyte K, Fraisl P, Dresselaers T, Mazzone M, Dirkx R, Zacchigna S, Lemieux H, Jeoung NH, Lambrechts D, Bishop T, Lafuste P, Diez-Juan A, Harten SK, Van Noten P, De Bock K, Willam C, Tjwa M, Grosfeld A, Navet R, Moons L, Vandendriessche T, Deroose C, Wijeyekoon B, Nuyts J, Jordan B, Silasi-Mansat R, Lupu F, Dewerchin M, Pugh C, Salmon P, Mortelmans L, Gallez B, Gorus F, Buyse J, Sluse F, Harris RA, Gnaiger E, Hespel P, Van Hecke P, Schuit F, Van Veldhoven P, Ratcliffe P, Baes M, Maxwell P, Carmeliet P. 2008. Deficiency or inhibition of oxygen sensor Phd1 induces hypoxia tolerance by reprogramming basal metabolism. Nat Genet 40:170-180.
3. Barrett TD, Palomino HL, Brondstetter TI, Kanelakis KC, Wu X, Haug PV, Yan W, Young A, Hua H, Hart JC, Tran DT, Venkatesan H, Rosen MD, Peltier HM, Sepassi K, Rizzolio MC, Bembenek SD, Mirzadegan T, Rabinowitz MH, Shankley NP. 2011. Pharmacological characterization of 1-(5-chloro-6- carboxylic acid (JNJ-42041935), a potent and selective hypoxia-inducible factor prolyl hydroxylase inhibitor. Peptide Res 79:910-920.
4. Batti L, O'Connor JJ. 2010. Tumor necrosis factor-alpha impairs the recovery of synaptic transmission from hypoxia in rat hippocampal slices. J Neuroimmunol 218:21-27.
5. Batti L, Taylor CT, O'Connor JJ. 2010. Hydroxylase inhibition reduces synaptic transmission and protects against a glutamate-induced ischemia in the CA1 region of the rat hippocampus. Neuroscience 167:1014-1024.
6. Chen R, Nagel S, Papadakis M, Bishop T, Pollard P, Ratcliffe PJ, Pugh CW, Buchan AM. 2012. Roles of individual prolyl-4-hydroxylase isoforms in the first 24 hours following transient focal cerebral ischaemia: insights from genetically modified mice. J Physiol 16:4079-4091.
7. Chen W, Jadhav V, Tang J, Zhang JH. 2008. HIF-1alpha inhibition ameliorates neonatal brain injury in a rat pup hypoxic-ischemic model. Neurobiol Dis 31:433-441.
8. Cummins EP, Berra E, Comerford KM, Ginouves A, Fitzgerald KT, Seeballuck F, Godson C, Nielsen JE, Moynagh P, Pouyssegur J, Taylor CT. 2006. Prolyl hydroxylase-1 negatively regulates IkappaB kinase-beta, giving insight into hypoxia-induced NFkappaB activity. PNAS 103:18154-18159.
9. Forsythe JA, Jiang BH, Iyer NV, Agani F, Leung SW, Koos RD, Semenza GL. 1996. Activation of vascular endothelial growth factor gene transcription by hypoxia-inducible factor 1. Mol Cell Biol 16:4604-4613.
10. Franke K, Kalucka J, Mamlouk S, Singh RP, Muschter A, Weidemann A, Iyengar V, Jahn S, Wieczorek K, Geiger K, Muders M, Sykes AM, Poitz DM, Ripich T, Otto T, Bergmann S, Breier G, Baretton G, Fong GH, Greaves DR, Bornstein S, Chavakis T, Fandrey J, Gassmann M, Wielockx B. 2013. HIF-1 is a protective factor in conditional PHD2 deficient mice suffering from severe HIF-2alpha-induced excessive erythroiesis. Blood 121:1436-1445.
11. Fu J, Taubman MB. 2010. Prolyl hydroxylase EGLN3 regulates skeletal myoblast differentiation through an NF-kappaB-dependent pathway. J Biol Chem 285:8927-8935.
12. Hölscher M, Silter M, Krull S, Ahlen M von, Hesse A, Schwartz P, Wielockx B, Breier G, Katschinski DM, Zieseniss A. 2011. Cardiomyocyte-specific prolyl-4-hydroxylase domain 2 knock out protects from acute myocardial ischemic injury. J Biol Chem 286:11185-11194.
13. Huang Y-F, Yang C-H, Huang C-C, Tai M-H, Hsu K-S. 2010. Pharmacological and genetic accumulation of hypoxia-inducible factor-1alpha enhances excitatory synaptic transmission in hippocampal neurons through the production of vascular endothelial growth factor. J Neurosci30:6080-6093.
14. Huo Z, Ye J-C, Chen J, Lin X, Zhou Z-N, Xu X-R, Li C-M, Qi M, Liang D, Liu Y, Li J. 2012. Prolyl hydroxylase domain protein 2 regulates the intracellular cyclic AMP level in cardiomyocytes through its interaction with phosphodiesterase 4D. Biochem Biophys Res Comm 427:73-79.
15. 2 sensing. Science 292:464-468.
16. 2-regulated prolyl hydroxylation. Science 292:468-472.
17. Kaelin WG, Ratcliffe PJ. 2008. Oxygen sensing by metazoans: The central role of the HIF hydroxylase. Mol Cell 30:393-402.
18. Kasiganesan H, Sridharan V, Wright G. 2007. Prolyl hydroxylase inhibitor treatment confers whole-animal hypoxia tolerance. Acta Physiologica 190:163-169.
19. Kim S, Lee K-Y, Koh S-H, Park H-H, Yu H-J, Lee YJ. 2012. Role of the phosphatidylinositol 3-kinase and extracellular signal-regulated kinase pathways in the neuroprotective effects of cilnidipine against hypoxia in a primary culture of cortical neurons. Neurochem Int 61:1172-1182.
20. Kunze R, Zhou W, Veltkamp R, Wielockx B, Breier G, Marti HH. 2012. Neuron-specific prolyl-4-hydroxylase domain 2 knockout reduces brain injury after transient cerebral ischemia. Stroke 43:2748-2756.
21. Licht T, Goshen I, Avital A, Kreisel T, Zubedat S, Eavri R, Segal M. 2011. Reversible modulations of neuronal plasticity by VEGF. Proc Natl Acad Sci USA 108:5081-5086.
22. Lomb DJ, Desouza LA, Franklin JL, Freeman RS. 2009. Prolyl hydroxylase inhibitors depend on extracellular glucose and hypoxia-inducible factor 2 alpha to inhibit cell death caused by nerve growth factor (NGF) deprivation: Evidence that HIF-2alpha has a role in NGF-promoted survival of sympathetic neurons. Mol Pharmacol 75:1198-1209.
23. Lomb DJ, Straub J a, Freeman RS. 2007. Prolyl hydroxylase inhibitors delay neuronal cell death caused by trophic factor deprivation. J Neurochem 103:1897-1906.
24. McCloskey DP, Croll SD, Scharfman HE. 2005. Depression of synaptic transmission by vascular endothelial growth factor in adult rat hippocampus and evidence for increased efficacy after chronic seizures. J Neurosci 25:8889-8897.
25. Milosevic J, Adler I, Manaenko A, Schwarz SC, Walkinshaw G, Arend M, Flippin LA, Storch A, Schwarz J. 2009. Non-hypoxic stabilization of hypoxia-inducible factor alpha (HIF-1a): Relevance in neural progenitor / stem cells. Neurotoxicity Res 15:367-380.
26. Miyata T, Takizawa S, van Ypersele de Strihou C. 2011. Hypoxia. 1. Intracellular sensors for oxygen and oxidative stress: novel therapeutic targets. Am J Physiol Cell Physiol 300:C226-C231.
27. Munoz P, Humeres A, Elgueta C, Kirkwood A, Hidalgo C, Nu MT. 2011. Iron mediates n-methyl-d-aspartate receptor-dependent stimulation of calcium-induced pathways and hippocampal synaptic plasticity. J Biol Chem 286:13382-13392.
28. Nagel S, Papadakis M, Chen R, Hoyte LC, Brooks KJ, Gallichan D, Sibson NR, Pugh C, Buchan AM. 2011. Neuroprotection by dimethyloxalylglycine following permanent and transient focal cerebral ischemia in rats. J Cerebral Blood Flow Metabol 31:132-143.
29. Ogle ME, Gu X, Espinera AR, Wei L. 2012. Inhibition of prolyl hydroxylases by dimethyloxaloylglycine after stroke reduces ischemic brain injury and requires hypoxia inducible factor-1α. Neurobiol Dis 45:733-742.
30. Palmer LA, Semenza GL, Stoler MH, Johns RA, Lisa A. 1998. Hypoxia induces type II NOS gene expression in pulmonary artery endothelial cells via HIF-1. Am J Phsiol Lung Cell Mol Physiol 274:L212-219.
31. Park EC, Ghose P, Shao Z, Ye Q, Kang L, Xu XZS, Powell-Coffman JA, Rongo C. 2012. Hypoxia regulates glutamate receptor trafficking through an HIF-independent mechanism. EMBO J 31:1379-1393.
32. Rabie T, Kunze R, Marti HH. 2011. Impaired hypoxic response in senescent mouse brain. Int J Dev Neurosci 29:655-661.
33. Romano A, Freudenthal R, Merlo E, Routtenberg A. 2006. Evolutionarily-conserved role of the NF-kappaB transcription factor in neural plasticity and memory. Neuroscience 24:1507-1516.
34. Rothwell PM. 2001. The high cost of not funding stroke research: A comparison with heart disease and cancer. Lancet 357:1612-1616.
35. Rutten K, Misner DL, Works M, Blokland A, Novak TJ, Santarelli L, Wallace TL. 2008. Enhanced long-term potentiation and impaired learning in phosphodiesterase 4D-knockout (PDE4D) mice. Eur J Neurosci 28:625-632.
36. Scholz KP, Miller RJ. 1996. Presynaptic inhibition at excitatory hippocampal synapses: Development and role of presynaptic Ca2+ channels. J Neurophysiol 76:39-46.
37. Sheridan GK, Pickering M, Twomey C, Moynagh PN, O'Connor JJ, Murphy KJ. 2007. NF-κ B activity in distinct neural subtypes of the rat hippocampus: Influence of time and GABA antagonism in acute slice preparations. Learn Mem 14:525-532.
38. Siddiq A, Ayoub IA, Chavez JC, Aminova L, Shah S, LaManna JC, Patton SM, Connor JR, Cherny RA, Volitakis I, Bush AI, Langsetmo I, Seeley T, Gunzler V, Ratan RR. 2005. Hypoxia-inducible factor prolyl 4-hydroxylase inhibition. A target for neuroprotection in the central nervous system. J Biol Chem 280:41732-41743.
39. 2 availability resolve the apparent discrepancies in metabolic intrinsic optical signals in vivo and in vitro. Trends Neurosci 30:390-398.
40. Wang GL, Semenza GL. 1993. Characterization of hypoxia-inducible factor 1 and regulation of DNA binding activity by hypoxia. J Biol Chem 268:21513-21518.
41. Willam C, Nicholls LG, Ratcliffe PJ, Pugh CW, Maxwell PH. 2004. The prolyl hydroxylase enzymes that act as oxygen sensors regulating destruction of hypoxia-inducible factor alpha. Advances Enzyme Reg 44:75-92.
42. Wong BW, Kuchnio A, Bruning U, Carmeliet P. 2013. Emerging novel functions of the oxygen-sensing prolyl hydroxylase domain enzymes. Trends Biochem Sci 38:3-11.
43. Wu LG, Saggau P. 1994. Adenosine inhibits evoked synaptic transmission primarily by reducing presynaptic calcium influx in area CA1 of hippocampus. Neuron 12:1139-1148.